Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Shandong Second Medical University | China

Author Profile

Scopus

🌟 Dr. Lv Huaiqing, M.D.

Chief Physician & Master’s Degree Supervisor

Director of Otorhinolaryngology & Head and Neck Surgery

Linyi People’s Hospital, Shandong Province

👩‍⚕️ Professional Summary:

Dr. Lv Huaiqing is a distinguished Chief Physician and subject leader at Linyi People’s Hospital, specializing in Otorhinolaryngology and Head and Neck Surgery. With extensive experience in clinical practice and research, Dr. Lv has significantly contributed to the field through her leadership roles and numerous scientific projects.

**🌐 Part-Time Roles:

  • Vice Chairman, Otorhinolaryngology, Head and Neck Surgery Committee, Shandong Provincial Medical Association
  • Vice Chairman, Hearing and Balance Medical Association, Shandong Provincial Medical Association
  • Member, Voice Committee, Otorhinolaryngology Committee, Chinese Association of Integrative Medicine
  • Standing Member, Head and Neck Tumor Committee, China Medical Education Association
  • Vice Chairman, Ear, Nose and Throat Committee, Shandong Association of Integrative Medicine
  • Vice Chairman, Pharyngeal, Head and Neck Surgery Committee, Shandong Provincial Association of Health Management
  • Director, Linyi Otorhinolaryngology Quality Control Center
  • Linyi Health Leader
  • Director, Otolaryngology Branch, Linyi Physicians Association

📚 Research Contributions:

Dr. Lv has authored 13 papers as the first author or corresponding author in the past year. She has presided over 3 provincial and municipal level projects, including:

  • Application of Posterior Auricular Groove Incision in Surgery of Benign Tumor of Parotid Gland
  • Evaluation of Orbital Invasion of Sinus Tumor Based on CT, MRI, and Machine Learning Models
  • Posterior Auricular Groove Incision in Surgery of Benign Tumor of Superficial Parotid Gland

Her research has received significant funding of 400,000 RMB and has led to several municipal science and technology awards. The research team excels in various methods, including bioinformatics, meta-analysis, and machine learning predictive models.

🎓 Teaching Commitment:

Currently, Dr. Lv supervises Master’s degree students at Qingdao University, Shandong Second Medical University, and Binzhou Medical College, having guided 10 students to date.

🔬 Current Publications:

She is also the first author or corresponding author of approximately 20 newly accepted and submitted articles in Chinese core or SCI journals.

Dr. Lv Huaiqing’s dedication to otorhinolaryngology, combined with her commitment to research and education, makes her a leading figure in her field.

🔔 Conclusion

Dr. Lv Huaiqing stands out as a prominent leader in Otorhinolaryngology and Head and Neck Surgery, with a rich background in clinical practice, research, and education. Her extensive involvement in various medical associations and committees demonstrates her commitment to advancing the field and enhancing patient care. Through her innovative research projects and dedication to mentoring future healthcare professionals, Dr. Lv continues to make significant contributions to medical science and the development of her specialty in Shandong Province and beyond.

📊🔬NOTABLE PUBLICATION:

    • Circ_0058124 upregulates MAPK1 expression to promote proliferation, metastasis and metabolic abilities in thyroid cancer through sponging miR-940
      • Authors: Sun, D., Chen, L., Lv, H., Liu, X., Zhang, X.
      • Journal: OncoTargets and Therapy
      • Year: 2020

     

    • Predicting biomarkers in laryngeal squamous cell carcinoma based on the cytokine-cytokine receptor interaction pathway
      • Authors: Chen, Q., Wang, D., Chen, Z., Li, P., Lv, H.
      • Journal: Heliyon
      • Year: 2024

     

    • Genetically predicted allergic rhinitis causally increases the risk of erectile dysfunction
      • Authors: Li, P., Meng, Z., Lin, L., Chen, Z., Lv, H.
      • Journal: Frontiers in Genetics
      • Year: 2024

     

    • A novel frameshift mutation of the endoglin (ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family
      • Authors: Li, P., Gao, C., Wei, Y., Shao, Q., Lv, H.
      • Journal: European Archives of Oto-Rhino-Laryngology
      • Year: 2024

     

    • Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway
      • Authors: Chen, L., Sun, D.-Z., Fu, Y.-G., Gao, Y., Zhang, X.-Y.
      • Journal: Cellular Signalling
      • Year: 2020

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

IQVIA | Netherlands 

Author Profile

Scopus

🌍Mrs. Anke van Engen 💼

  • Managing Principal, IQVIA Payer Evidence Solutions
    Amsterdam, the Netherlands

🔬Profile:

  • Anke van Engen is a seasoned expert with over 20 years of experience in health economics, outcomes research, and market access strategy. Her work focuses on helping life sciences companies achieve greater commercial success through integrated payer evidence strategies. Anke is well-regarded for building lasting partnerships, consistently delivering results, and serving as a trusted advisor to clients. She excels at leading international teams across EMEA, using her coaching and training abilities to inspire success.

👨‍⚕️Key Specialties:

  • 📚General management
  • 🌍Strategic planning & business development
  • 🩺Health economics & outcomes research (HEOR)
  • 🏥Market access strategy (MA) & execution
  • 💉Health technology assessment (HTA)
  • 📍Client relationship management & coaching

💼Professional Experience:

  • 🌟2023 – Present: Managing Principal, IQVIA Value & Payer Evidence
    • Co-leads EMEA Real World Evidence Leadership Team
    • Oversees integrated evidence & EU HTA offerings
  • 💡2020 – 2023: Senior Principal, IQVIA Real World Solutions
    • Led the development of EMEA payer evidence solutions
    • Drove go-to-market strategy and key client partnerships
  • 🌐2017 – 2020: Senior Principal, IQVIA Consulting Services
    • Managed partnerships with large pharmaceutical clients
    • Led the HTA Accelerator solution for launch readiness
  • 🚀2014 – 2017: Principal, Quintiles Advisory Services
    • Led development of the flagship HTA Accelerator platform
    • Senior oversight on HEOR/MA strategy and projects

🎓Education:

  • 🧪MSc in Chemistry (Bio-organic Chemistry), University of Leiden, The Netherlands
  • 📊Business leadership programs at IMD, Lausanne, Switzerland

🌐Professional Affiliations:

  • 🧬Active member of ISPOR and HTAi
  • 💡IQVIA representative at GetReal Institute

🏅Awards & Honors:

  • 🌟2023: Issue panel ranked #1 at ISPOR Europe
  • 🦈2014: Won Sharktank contest for HTA Accelerator innovation
  • 🏆Multiple ISPOR awards for best podium and poster presentations

 

🔍 Conclusion
  • 💼In conclusion, Anke van Engen is a highly respected leader in the field of health economics, outcomes research, and market access strategy, with a proven track record of guiding life sciences companies toward commercial success. Her expertise in building long-term client partnerships, managing international teams, and delivering innovative payer evidence solutions has solidified her reputation as a trusted advisor. With over two decades of experience and numerous accolades, Anke continues to shape the future of healthcare consultancy by integrating strategic insights and real-world evidence. 🌍

 

📊🔬NOTABLE PUBLICATION:

 

    • The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment
      • Authors: van Engen A, Krüger R, Parnaby A, Rotaru M, Ryan J, Samaha D, Tzelis D
      • Journal: Value Health
      • Year: 2024

     

    • Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials
      • Authors: Patel D, Grimson F, Mihaylova E, Wagner P, Warren J, van Engen A, Kim J
      • Journal: Value Health
      • Year: 2021

     

    • Call in the PROs: Giving Credence to the Patient’s Perspective in Healthcare Decision Making
      • Authors: van Engen A, New M, Beatrice Böhler Y, Holmstrom S, Boerlum Kristensen F
      • Journal: ISPOR Value & Outcomes Spotlight
      • Year: 2020